Zobrazeno 1 - 10
of 257
pro vyhledávání: '"Aa, Garcia"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S563-S564 (2024)
Factor VIII (FVIII) prophylaxis is recommended to prevent bleeds in people with hemophilia A (PwHA). However, up to 30% of severe PwHA (residual plasmatic FVIII activity < 1%) develop anti-FVIII (FVIII) neutralizing antibodies (i.e., inhibitors), lea
Externí odkaz:
https://doaj.org/article/aa65dcde749545bda270852ac5b4c0f8
Autor:
RM Camelo, LCM Henriques, BRAD Santos, MCS Assunção, Silveira da EO, LEM Carvalho, TO Rebouças, MB Swain, MLA Ferreira, AV Gonçalves, ISS Pinto, SS Figueiredo, ES Casaretto, AM Vanderlei, IM Costa, NCM Costa, TMR Guimarães, MP Santana, CB Ferreira, AC Luz, F Campoy, JSS Filho Ferreira, AA Garcia, B Cabrera, PC Giacometto, J Alvares-Teodoro
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S590-S591 (2024)
Profilaxia com emicizumabe é recomendada para evitar eventos hemorrágicos em pessoas com hemofilia A e inibidores (PcHAi). O objetivo desta análise foi comparar a efetividade do primeiro ano de profilaxia com emicizumabe com o tratamento anterior
Externí odkaz:
https://doaj.org/article/a43857abaf014f5f906058f667d45c10
Autor:
VG Freitas, AA Garcia, NR Ziolle, CCI Streicher, MCL Falco, IG Vitoriano, MS Urazaki, I Garbin, GM Raitz, LN Farinazzo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S245- (2021)
Objetivo: Relatar e discutir as abordagens diagnóstica e terapêutica de um caso de tromboembolismo pulmonar (TEP) por trombocitopenia induzida por heparina (HIT). Metodologia: Dados obtidos por revisão de prontuário eletrônico, após autorizaç
Externí odkaz:
https://doaj.org/article/2970f13090d740ca89d8d5e4a1b27e21
Autor:
MCL Falco, AA Garcia, VG Freitas, CCI Streicher, NR Ziolle, IG Vitoriano, MS Urazaki, I Garbin, GM Raitz, NF Beccari
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S417-S418 (2021)
Objetivo: Relatar caso de doença de von Willebrand (DVW) do tipo 3 com níveis de antígeno de Von Willebrand (FVW:Ag) falsamente elevados pela presença de fator reumatoide (FR). Metodologia: Dados obtidos por meio de entrevista clínica em consult
Externí odkaz:
https://doaj.org/article/341ab8eb494d45bbb4cfb1a786c65165
Autor:
M Aguar Carrascosa, Á Solaz García, I Lara Cantón, AA Garcia Robles, A Cruz Sánchez, JL Poveda Andrés, A Pinilla González, Á Sánchez Illana
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2772b7cc5b75c16a66bcb9b393ddf82
https://doi.org/10.1136/ejhpharm-2022-eahp.423
https://doi.org/10.1136/ejhpharm-2022-eahp.423
Autor:
AA Garcia Robles, MDM Serrano Martin, MJ Párraga, E Guerrero Hurtado, P Polo Montanero, JL Poveda Andrés, M Aguar Carrascosa, A Gimeno Navarro
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3839cba743d1e09694ccd17e2972250
https://doi.org/10.1136/ejhpharm-2022-eahp.430
https://doi.org/10.1136/ejhpharm-2022-eahp.430
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S495
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7a80ec87ff4e40593b45e1a164c988e
https://doi.org/10.1016/j.htct.2022.09.845
https://doi.org/10.1016/j.htct.2022.09.845
Publikováno v:
Value in Health. 25:S91-S92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d1b6bf8ec0d7da0b7ef2a2fef074671
https://doi.org/10.1016/j.jval.2021.11.433
https://doi.org/10.1016/j.jval.2021.11.433
Publikováno v:
Value in Health. 25:S92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2de285d8e96dad3c4ce8d6f1f9132a25
https://doi.org/10.1016/j.jval.2021.11.434
https://doi.org/10.1016/j.jval.2021.11.434
Autor:
NK Ibrahim, S-C Tang, AJ Brenner, S Kesari, DE Piccioni, CK Anders, JA Carillo, P Chalasani, P Kabos, S Puhalla, AA Garcia, KH Tkaczuk, MS Ahluwalia, NJ Lakhani, P Kumthekar
Publikováno v:
Cancer Research. 77:P1-12
Background: The incidence of CNS metastatic disease in breast cancer patients (pts) seems to have increased in recent years with the improvement of systemic therapy. However, treatment options for CNS metastases have remained limited due to the inabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f6e65d983fd4de3894079d8fb49e82c
https://doi.org/10.1158/1538-7445.sabcs16-p1-12-01
https://doi.org/10.1158/1538-7445.sabcs16-p1-12-01